Cargando…

The theranostic potentialities of bioavailable nanocurcumin in oral cancer management

BACKGROUND: Oral cancer, one of the most common cancers, has unimproved 5-years survival rate in the last 30 years and the chemo/radiotherapy-associated morbidity. Therefore, intervention strategies that evade harmful side effects of the conventional treatment modalities are of need. Herbal therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Essawy, Marwa M., Mohamed, Mostafa M., Raslan, Hanaa S., Rafik, Salma T., Awaad, Ashraf K., Ramadan, Omneya R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685877/
https://www.ncbi.nlm.nih.gov/pubmed/36424593
http://dx.doi.org/10.1186/s12906-022-03770-3
_version_ 1784835617438302208
author Essawy, Marwa M.
Mohamed, Mostafa M.
Raslan, Hanaa S.
Rafik, Salma T.
Awaad, Ashraf K.
Ramadan, Omneya R.
author_facet Essawy, Marwa M.
Mohamed, Mostafa M.
Raslan, Hanaa S.
Rafik, Salma T.
Awaad, Ashraf K.
Ramadan, Omneya R.
author_sort Essawy, Marwa M.
collection PubMed
description BACKGROUND: Oral cancer, one of the most common cancers, has unimproved 5-years survival rate in the last 30 years and the chemo/radiotherapy-associated morbidity. Therefore, intervention strategies that evade harmful side effects of the conventional treatment modalities are of need. Herbal therapy as a complementary preventive/therapeutic modality has gained attention. Curcumin is one of the herbal compounds possessing unique anticancer activity and luminescent optical properties. However, its low water solubility limits its efficacy. In contrast, curcumin at the nanoscale shows altered physical properties with enhancing bioavailability. METHODS: The current study evaluated the impact of nanocurcumin as an anti-oral cancer herbal remedy, comparing its efficacy against the native curcumin complement and conventional chemotherapeutic. An optimized polymeric-stabilized nanocurcumin was synthesized using the solvent-antisolvent precipitation technique. After assuring the solubility and biocompatibility of nanocurcumin, we determined its cytotoxic dose in treating the squamous cell carcinoma cell line. We then evaluated the anti-tumorigenic activity of the nano-herb in inhibiting wound closure and the cytological alterations of the treated cancer cells. Furthermore, the cellular uptake of the nanocurcumin was assessed depending on its autofluorescence. RESULTS: The hydrophilic optimized nanocurcumin has a potent cancerous cytotoxicity at a lower dose (60.8 µg/mL) than the native curcumin particles (212.4 µg/mL) that precipitated on high doses hindering their cellular uptake. Moreover, the nanocurcumin showed differential targeting of the cancer cells over the normal fibroblasts with a selectivity index of 4.5. With the confocal microscopy, the luminescent nanoparticles showed gradual nuclear and cytoplasmic uptake with apparent apoptotic cell death, over the fluorescent doxorubicin with its necrotic effect. Furthermore, the nanocurcumin superiorly inhibited the migration of cancer cells by -25%. CONCLUSIONS: The bioavailable nanocurcumin has better apoptotic cytotoxicity. Moreover, its superior luminescence promotes the theranostic potentialities of the nano-herb combating oral cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-022-03770-3.
format Online
Article
Text
id pubmed-9685877
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96858772022-11-25 The theranostic potentialities of bioavailable nanocurcumin in oral cancer management Essawy, Marwa M. Mohamed, Mostafa M. Raslan, Hanaa S. Rafik, Salma T. Awaad, Ashraf K. Ramadan, Omneya R. BMC Complement Med Ther Research BACKGROUND: Oral cancer, one of the most common cancers, has unimproved 5-years survival rate in the last 30 years and the chemo/radiotherapy-associated morbidity. Therefore, intervention strategies that evade harmful side effects of the conventional treatment modalities are of need. Herbal therapy as a complementary preventive/therapeutic modality has gained attention. Curcumin is one of the herbal compounds possessing unique anticancer activity and luminescent optical properties. However, its low water solubility limits its efficacy. In contrast, curcumin at the nanoscale shows altered physical properties with enhancing bioavailability. METHODS: The current study evaluated the impact of nanocurcumin as an anti-oral cancer herbal remedy, comparing its efficacy against the native curcumin complement and conventional chemotherapeutic. An optimized polymeric-stabilized nanocurcumin was synthesized using the solvent-antisolvent precipitation technique. After assuring the solubility and biocompatibility of nanocurcumin, we determined its cytotoxic dose in treating the squamous cell carcinoma cell line. We then evaluated the anti-tumorigenic activity of the nano-herb in inhibiting wound closure and the cytological alterations of the treated cancer cells. Furthermore, the cellular uptake of the nanocurcumin was assessed depending on its autofluorescence. RESULTS: The hydrophilic optimized nanocurcumin has a potent cancerous cytotoxicity at a lower dose (60.8 µg/mL) than the native curcumin particles (212.4 µg/mL) that precipitated on high doses hindering their cellular uptake. Moreover, the nanocurcumin showed differential targeting of the cancer cells over the normal fibroblasts with a selectivity index of 4.5. With the confocal microscopy, the luminescent nanoparticles showed gradual nuclear and cytoplasmic uptake with apparent apoptotic cell death, over the fluorescent doxorubicin with its necrotic effect. Furthermore, the nanocurcumin superiorly inhibited the migration of cancer cells by -25%. CONCLUSIONS: The bioavailable nanocurcumin has better apoptotic cytotoxicity. Moreover, its superior luminescence promotes the theranostic potentialities of the nano-herb combating oral cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-022-03770-3. BioMed Central 2022-11-24 /pmc/articles/PMC9685877/ /pubmed/36424593 http://dx.doi.org/10.1186/s12906-022-03770-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Essawy, Marwa M.
Mohamed, Mostafa M.
Raslan, Hanaa S.
Rafik, Salma T.
Awaad, Ashraf K.
Ramadan, Omneya R.
The theranostic potentialities of bioavailable nanocurcumin in oral cancer management
title The theranostic potentialities of bioavailable nanocurcumin in oral cancer management
title_full The theranostic potentialities of bioavailable nanocurcumin in oral cancer management
title_fullStr The theranostic potentialities of bioavailable nanocurcumin in oral cancer management
title_full_unstemmed The theranostic potentialities of bioavailable nanocurcumin in oral cancer management
title_short The theranostic potentialities of bioavailable nanocurcumin in oral cancer management
title_sort theranostic potentialities of bioavailable nanocurcumin in oral cancer management
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685877/
https://www.ncbi.nlm.nih.gov/pubmed/36424593
http://dx.doi.org/10.1186/s12906-022-03770-3
work_keys_str_mv AT essawymarwam thetheranosticpotentialitiesofbioavailablenanocurcumininoralcancermanagement
AT mohamedmostafam thetheranosticpotentialitiesofbioavailablenanocurcumininoralcancermanagement
AT raslanhanaas thetheranosticpotentialitiesofbioavailablenanocurcumininoralcancermanagement
AT rafiksalmat thetheranosticpotentialitiesofbioavailablenanocurcumininoralcancermanagement
AT awaadashrafk thetheranosticpotentialitiesofbioavailablenanocurcumininoralcancermanagement
AT ramadanomneyar thetheranosticpotentialitiesofbioavailablenanocurcumininoralcancermanagement
AT essawymarwam theranosticpotentialitiesofbioavailablenanocurcumininoralcancermanagement
AT mohamedmostafam theranosticpotentialitiesofbioavailablenanocurcumininoralcancermanagement
AT raslanhanaas theranosticpotentialitiesofbioavailablenanocurcumininoralcancermanagement
AT rafiksalmat theranosticpotentialitiesofbioavailablenanocurcumininoralcancermanagement
AT awaadashrafk theranosticpotentialitiesofbioavailablenanocurcumininoralcancermanagement
AT ramadanomneyar theranosticpotentialitiesofbioavailablenanocurcumininoralcancermanagement